Balogun Zainab, Wiener Alysia, Berger Jessica, Lesnock Jamie, Garrett Alison A
University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.
Department of Obstetrics, Gynecology, and Reproductive Sciences, Magee-Womens Hospital, Pittsburgh, PA, United States.
Gynecol Oncol Rep. 2024 Jul 21;55:101467. doi: 10.1016/j.gore.2024.101467. eCollection 2024 Oct.
Sentinel lymph node (SLN) mapping is a surgical technique with high accuracy in detecting metastases while limiting morbidity associated with full lymphadenectomy in endometrial cancer. Cervical injection of indocyanine green (ICG) dye is associated with very high SLN detection rates; however, iodinated contrast allergy has traditionally been viewed as a contraindication to ICG use. The objective of this study was to describe the use of ICG in a population of patients with iodinated contrast allergies undergoing surgical staging for endometrial cancer.
IRB approval was obtained. All patients with clinically early-stage endometrial cancer who underwent minimally invasive surgical staging with SLN mapping with ICG at a single academic institution from 1/1/2017 to 12/31/2020 were identified retrospectively. Patients with reported iodinated contrast allergies prior to surgery were identified. Data were collected through electronic medical record review and compared using descriptive statistics.
820 patients who underwent minimally invasive surgical staging with SLN mapping with ICG were identified, and 25 had documented iodinated contrast allergies. Documented reactions included rash/hives (n = 10, 40 %), anaphylaxis (n = 6, 24 %), shortness of breath (n = 5, 20 %), diarrhea (n = 1, 4 %), and not specified (n = 3, 12 %). A majority (24/25, 96 %) received 4 mg intravenous dexamethasone during induction of general anesthesia as per the institutional enhanced recovery after surgery (ERAS) protocol. No patients experienced allergic reactions or other adverse events after ICG injection.
No patients in this cohort demonstrated an adverse reaction after ICG injection for SLN mapping. This study supports the reasonable safety of ICG in patients with contrast allergies, particularly when routine ERAS protocols containing dexamethasone are utilized.
前哨淋巴结(SLN)定位是一种手术技术,在检测子宫内膜癌转移方面具有很高的准确性,同时可降低与根治性淋巴结清扫术相关的发病率。宫颈注射吲哚菁绿(ICG)染料的前哨淋巴结检测率非常高;然而,传统上碘造影剂过敏被视为使用ICG的禁忌症。本研究的目的是描述ICG在接受子宫内膜癌手术分期的碘造影剂过敏患者中的应用。
获得机构审查委员会(IRB)批准。回顾性确定2017年1月1日至2020年12月31日期间在单一学术机构接受ICG前哨淋巴结定位微创外科分期的所有临床早期子宫内膜癌患者。确定术前报告有碘造影剂过敏的患者。通过电子病历回顾收集数据,并使用描述性统计进行比较。
确定了820例接受ICG前哨淋巴结定位微创外科分期的患者,其中25例有碘造影剂过敏记录。记录的反应包括皮疹/荨麻疹(n = 10,40%)、过敏反应(n = 6,24%)、呼吸急促(n = 5,20%)、腹泻(n = 1,4%)和未明确说明(n = 3,12%)。根据机构术后加速康复(ERAS)方案,大多数患者(24/25,96%)在全身麻醉诱导期间接受了4mg静脉注射地塞米松。ICG注射后没有患者出现过敏反应或其他不良事件。
该队列中没有患者在ICG注射用于前哨淋巴结定位后出现不良反应。本研究支持ICG在造影剂过敏患者中的合理安全性,特别是在使用包含地塞米松的常规ERAS方案时。